Alrawili, H.M.; Elshal, M.; Serrya, M.S.; El-Agamy, D.S.
The Gut Microbiota Metabolite Urolithin B Mitigates Cholestatic Liver Injury in Mice via Modulating the Crosstalk Between PPARα, Nrf2, and NF-κB Signaling Pathways. J. Xenobiot. 2025, 15, 128.
https://doi.org/10.3390/jox15040128
AMA Style
Alrawili HM, Elshal M, Serrya MS, El-Agamy DS.
The Gut Microbiota Metabolite Urolithin B Mitigates Cholestatic Liver Injury in Mice via Modulating the Crosstalk Between PPARα, Nrf2, and NF-κB Signaling Pathways. Journal of Xenobiotics. 2025; 15(4):128.
https://doi.org/10.3390/jox15040128
Chicago/Turabian Style
Alrawili, Hani M., Mahmoud Elshal, Marwa S. Serrya, and Dina S. El-Agamy.
2025. "The Gut Microbiota Metabolite Urolithin B Mitigates Cholestatic Liver Injury in Mice via Modulating the Crosstalk Between PPARα, Nrf2, and NF-κB Signaling Pathways" Journal of Xenobiotics 15, no. 4: 128.
https://doi.org/10.3390/jox15040128
APA Style
Alrawili, H. M., Elshal, M., Serrya, M. S., & El-Agamy, D. S.
(2025). The Gut Microbiota Metabolite Urolithin B Mitigates Cholestatic Liver Injury in Mice via Modulating the Crosstalk Between PPARα, Nrf2, and NF-κB Signaling Pathways. Journal of Xenobiotics, 15(4), 128.
https://doi.org/10.3390/jox15040128